Concepedia

Aaron Korkegian

AK

Statistics

Publications

16

Citations

785

H-Index

12

Active since

2005

Affiliations

Infectious Disease Research Institute(Current)

Eli Lilly (United States)

Texas A&M University

Colorado State University

Washington State University

Aaron Korkegian is an author at Infectious Disease Research Institute specializing in drug discovery, mycobacterium tuberculosis infection, and antibacterial pharmacology.

Publications per year

2005–2022

16

Publications

16

Computational Thermostabilization of an Enzyme

Aaron Korkegian, Margaret E. Black, David Baker et al. · Science · 2005 · 364 citations

, , +17

Identification of Morpholino Thiophenes as Novel <i>Mycobacterium tuberculosis</i> Inhibitors, Targeting QcrB

Laura A. T. Cleghorn, Peter C. Ray, Joshua Odingo et al. · Journal of Medicinal Chemistry · 2018 · 57 citations · Full text

, , +15

The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents

Edison S. Zuniga, Aaron Korkegian, Steven F. Mullen et al. · Bioorganic & Medicinal Chemistry · 2017 · 55 citations · Full text

, , +13

Discovery of a cofactor-independent inhibitor of<i>Mycobacterium tuberculosis</i>InhA

Yi Xia, Yasheen Zhou, David S. Carter et al. · Life Science Alliance · 2018 · 48 citations · Full text

, , +17

Yeast Cytosine Deaminase Mutants with Increased Thermostability Impart Sensitivity to 5-Fluorocytosine

Tiffany S. Stolworthy, Aaron Korkegian, Candice Willmon et al. · Journal of Molecular Biology · 2008 · 42 citations · Full text

, , +10

1–5 of 16